Urologix, Inc. Stock
Stocks
ULGX
US9172731047
Mining Support Services & Equipment
OTC Markets Traded|
Delayed
OTC Markets
02:57:34 03/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
+9,900.00% | - |
| 02/02/16 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
| 09/07/15 | Urologix Conducting A Strategic Review | CI |
| Market Cap | 2.13M 1.91M 1.74M 1.59M 3M 200M 3.09M 21.03M 8.38M 107M 7.99M 7.82M 337M | P/E 2013 |
-0.8x | P/E 2014 | -0.49x |
|---|---|---|---|---|---|
| Enterprise Value | 6.74M 6.05M 5.53M 5.05M 9.51M 634M 9.81M 66.62M 26.57M 338M 25.31M 24.77M 1.07B | EV / Sales 2013 |
0.4x | EV / Sales 2014 | 0.59x |
| Free-Float |
100% | Yield 2013 * |
-
| Yield 2014 | - |
| 1 day | +9,900.00% | ||
| 1 week | +9,900.00% | ||
| Current month | +9,900.00% |
| 1 week | 0 | 0 | |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.02 | |
| 1 year | 0 | 0.02 | |
| 3 years | 0 | 0.04 | |
| 5 years | 0 | 0.04 | |
| 10 years | 0 | 0.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lisa Ackermann
SAM | Sales & Marketing | 53 | 16/06/2011 |
| Director | Title | Age | Since |
|---|---|---|---|
Mitchell Dann
CHM | Chairman | 65 | 29/05/1991 |
Sidney Emery
BRD | Director/Board Member | 76 | 03/10/2005 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +9,900.00% | +9,900.00% | 0.00% | 0.00% | 2.13K | ||
| -0.42% | -0.42% | +24.44% | +83.14% | 45.98B | ||
| -7.52% | -6.56% | -12.40% | +57.60% | 5.56B | ||
| -0.18% | -4.21% | +19.18% | +109.77% | 4.47B | ||
| -0.52% | +10.30% | -34.90% | +18.75% | 3.87B | ||
| -1.08% | +6.12% | -15.99% | +57.42% | 3.85B | ||
| +1.14% | +7.26% | -13.21% | +3.30% | 3.26B | ||
| -10.00% | +17.74% | +63.12% | +263.04% | 2.81B | ||
| -0.44% | -13.27% | -5.87% | -29.31% | 2.84B | ||
| -0.64% | +4.00% | -32.22% | -11.03% | 1.75B | ||
| Average | +987.96% | -0.40% | -0.79% | +55.27% | 7.44B | |
| Weighted average by Cap. | -1.32% | -1.20% | +13.52% | +74.95% |
| 2013 | 2014 | |
|---|---|---|
| Net sales | 16.48M 14.78M 13.51M 12.33M 23.24M 1.55B 23.97M 163M 64.94M 827M 61.87M 60.55M 2.61B | 14.01M 12.57M 11.49M 10.48M 19.75M 1.32B 20.38M 138M 55.2M 703M 52.59M 51.47M 2.22B |
| Net income | -4.29M -3.85M -3.52M -3.21M -6.05M -403M -6.24M -42.41M -16.91M -215M -16.11M -15.76M -680M | -7.61M -6.82M -6.24M -5.69M -10.73M -715M -11.06M -75.17M -29.97M -382M -28.56M -27.94M -1.2B |
| Net Debt | 3.04M 2.73M 2.49M 2.28M 4.29M 286M 4.43M 30.07M 11.99M 153M 11.42M 11.18M 482M | 4.62M 4.14M 3.78M 3.45M 6.51M 434M 6.71M 45.6M 18.18M 231M 17.32M 16.95M 731M |
Employees
61
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- ULGX Stock
Select your edition
All financial news and data tailored to specific country editions
















